OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tumor immunosuppressive environment: effects on tumor-specific and nontumor antigen immune responses
Ana Paula Duarte de Souza, Cristina Bonorino
Expert Review of Anticancer Therapy (2009) Vol. 9, Iss. 9, pp. 1317-1332
Closed Access | Times Cited: 71
Ana Paula Duarte de Souza, Cristina Bonorino
Expert Review of Anticancer Therapy (2009) Vol. 9, Iss. 9, pp. 1317-1332
Closed Access | Times Cited: 71
Showing 1-25 of 71 citing articles:
Vitamin D and cancer: a review of molecular mechanisms
James C. Fleet, Marsha DeSmet, Robert L. Johnson, et al.
Biochemical Journal (2011) Vol. 441, Iss. 1, pp. 61-76
Open Access | Times Cited: 381
James C. Fleet, Marsha DeSmet, Robert L. Johnson, et al.
Biochemical Journal (2011) Vol. 441, Iss. 1, pp. 61-76
Open Access | Times Cited: 381
Gene therapy for cancer: present status and future perspective
Magid H. Amer
Molecular and Cellular Therapies (2014) Vol. 2, Iss. 1, pp. 27-27
Open Access | Times Cited: 222
Magid H. Amer
Molecular and Cellular Therapies (2014) Vol. 2, Iss. 1, pp. 27-27
Open Access | Times Cited: 222
The Anti-Inflammatory Effects of Vitamin D in Tumorigenesis
Wei Liu, Lei Zhang, Huijing Xu, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 9, pp. 2736-2736
Open Access | Times Cited: 172
Wei Liu, Lei Zhang, Huijing Xu, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 9, pp. 2736-2736
Open Access | Times Cited: 172
Exosome-Mediated Immunosuppression in Tumor Microenvironments
Qihui Xie, Jiqi Zheng, Jiayi Ding, et al.
Cells (2022) Vol. 11, Iss. 12, pp. 1946-1946
Open Access | Times Cited: 82
Qihui Xie, Jiqi Zheng, Jiayi Ding, et al.
Cells (2022) Vol. 11, Iss. 12, pp. 1946-1946
Open Access | Times Cited: 82
Cyclic AMP-mediated immune regulation — Overview of mechanisms of action in T cells
Randi Mosenden, Kjetil Taskén
Cellular Signalling (2010) Vol. 23, Iss. 6, pp. 1009-1016
Closed Access | Times Cited: 197
Randi Mosenden, Kjetil Taskén
Cellular Signalling (2010) Vol. 23, Iss. 6, pp. 1009-1016
Closed Access | Times Cited: 197
New Therapies for Castration-Resistant Prostate Cancer
Dan L. Longo
New England Journal of Medicine (2010) Vol. 363, Iss. 5, pp. 479-481
Closed Access | Times Cited: 128
Dan L. Longo
New England Journal of Medicine (2010) Vol. 363, Iss. 5, pp. 479-481
Closed Access | Times Cited: 128
Recent advances in exosome-based immunotherapy applied to cancer
Jindong Xie, Zihan Zheng, Ling Tuo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 27
Jindong Xie, Zihan Zheng, Ling Tuo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 27
Augmented anti-tumor activity of NK-92 cells expressing chimeric receptors of TGF-βR II and NKG2D
Zhongjuan Wang, Linghua Guo, Yuan Song, et al.
Cancer Immunology Immunotherapy (2017) Vol. 66, Iss. 4, pp. 537-548
Closed Access | Times Cited: 69
Zhongjuan Wang, Linghua Guo, Yuan Song, et al.
Cancer Immunology Immunotherapy (2017) Vol. 66, Iss. 4, pp. 537-548
Closed Access | Times Cited: 69
Immunomodulatory effects of Tinospora crispa extract and its major compounds on the immune functions of RAW 264.7 macrophages
Waqas Ahmad, Ibrahim Jantan, Endang Kumolosasi, et al.
International Immunopharmacology (2018) Vol. 60, pp. 141-151
Closed Access | Times Cited: 63
Waqas Ahmad, Ibrahim Jantan, Endang Kumolosasi, et al.
International Immunopharmacology (2018) Vol. 60, pp. 141-151
Closed Access | Times Cited: 63
Peptide-Based Nanovaccines in the Treatment of Cervical Cancer: A Review of Recent Advances
Jiahui Zhang, Jingyi Fan, Mariusz Skwarczyński, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 869-900
Open Access | Times Cited: 34
Jiahui Zhang, Jingyi Fan, Mariusz Skwarczyński, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 869-900
Open Access | Times Cited: 34
Fc gamma receptor polymorphisms as predictive markers of Cetuximab efficacy in epidermal growth factor receptor downstream-mutated metastatic colorectal cancer
J. Rodríguez, Ruth Zárate, Eva Bandrés, et al.
European Journal of Cancer (2012) Vol. 48, Iss. 12, pp. 1774-1780
Closed Access | Times Cited: 74
J. Rodríguez, Ruth Zárate, Eva Bandrés, et al.
European Journal of Cancer (2012) Vol. 48, Iss. 12, pp. 1774-1780
Closed Access | Times Cited: 74
Host B7x Promotes Pulmonary Metastasis of Breast Cancer
Yael M. Abadi, Hyungjun Jeon, Kim C. Ohaegbulam, et al.
The Journal of Immunology (2013) Vol. 190, Iss. 7, pp. 3806-3814
Open Access | Times Cited: 68
Yael M. Abadi, Hyungjun Jeon, Kim C. Ohaegbulam, et al.
The Journal of Immunology (2013) Vol. 190, Iss. 7, pp. 3806-3814
Open Access | Times Cited: 68
Modulation of T cell immune functions by the prostaglandin E2 – cAMP pathway in chronic inflammatory states
Kristoffer W. Brudvik, Kjetil Taskén
British Journal of Pharmacology (2011) Vol. 166, Iss. 2, pp. 411-419
Open Access | Times Cited: 67
Kristoffer W. Brudvik, Kjetil Taskén
British Journal of Pharmacology (2011) Vol. 166, Iss. 2, pp. 411-419
Open Access | Times Cited: 67
Pyrithione zinc alters mismatch repair to trigger tumor immunogenicity
Huanling Zhang, Jiaxin Wu, Lei Cui, et al.
Oncogene (2025)
Closed Access
Huanling Zhang, Jiaxin Wu, Lei Cui, et al.
Oncogene (2025)
Closed Access
Small-Molecule Protein Kinase Inhibitors and Their Effects on the Immune System: Implications for Cancer Treatment
Patrick A. Ott, Sylvia Adams
Immunotherapy (2011) Vol. 3, Iss. 2, pp. 213-227
Open Access | Times Cited: 59
Patrick A. Ott, Sylvia Adams
Immunotherapy (2011) Vol. 3, Iss. 2, pp. 213-227
Open Access | Times Cited: 59
Plant immunostimulants—Scientific paradigm or myth?
Jürg Gertsch, Juan Manuel Viveros–Paredes, Peter Taylor
Journal of Ethnopharmacology (2010) Vol. 136, Iss. 3, pp. 385-391
Closed Access | Times Cited: 54
Jürg Gertsch, Juan Manuel Viveros–Paredes, Peter Taylor
Journal of Ethnopharmacology (2010) Vol. 136, Iss. 3, pp. 385-391
Closed Access | Times Cited: 54
Splenectomy inhibits non-small cell lung cancer growth by modulating anti-tumor adaptive and innate immune response
Liran Levy, Inbal Mishalian, Rachel Bayuch, et al.
OncoImmunology (2015) Vol. 4, Iss. 4, pp. e998469-e998469
Open Access | Times Cited: 49
Liran Levy, Inbal Mishalian, Rachel Bayuch, et al.
OncoImmunology (2015) Vol. 4, Iss. 4, pp. e998469-e998469
Open Access | Times Cited: 49
Blocking transforming growth factor-β signaling pathway augments antitumor effect of adoptive NK-92 cell therapy
Bo Yang, Hui Liu, Weiwei Shi, et al.
International Immunopharmacology (2013) Vol. 17, Iss. 2, pp. 198-204
Closed Access | Times Cited: 47
Bo Yang, Hui Liu, Weiwei Shi, et al.
International Immunopharmacology (2013) Vol. 17, Iss. 2, pp. 198-204
Closed Access | Times Cited: 47
Genomics-Guided Immunotherapy for Precision Medicine in Cancer
Shradha Mukherjee
Cancer Biotherapy and Radiopharmaceuticals (2019) Vol. 34, Iss. 8, pp. 487-497
Open Access | Times Cited: 40
Shradha Mukherjee
Cancer Biotherapy and Radiopharmaceuticals (2019) Vol. 34, Iss. 8, pp. 487-497
Open Access | Times Cited: 40
Combination Radioimmunotherapy Strategies for Solid Tumors
Javeria Zaheer, Hyeongi Kim, Yong-Jin Lee, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 22, pp. 5579-5579
Open Access | Times Cited: 35
Javeria Zaheer, Hyeongi Kim, Yong-Jin Lee, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 22, pp. 5579-5579
Open Access | Times Cited: 35
Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity
Ryan A. Heiser, Anthony Cao, Weiping Zeng, et al.
Molecular Cancer Therapeutics (2023) Vol. 23, Iss. 1, pp. 68-83
Open Access | Times Cited: 12
Ryan A. Heiser, Anthony Cao, Weiping Zeng, et al.
Molecular Cancer Therapeutics (2023) Vol. 23, Iss. 1, pp. 68-83
Open Access | Times Cited: 12
Effects of exercise on immune cells with tumor-specific activity in breast cancer patients and survivors: a systematic review and meta-analysis
Ana Myriam Lavín‐Pérez, Daniel Collado‐Mateo, Shaghayegh Abbasi, et al.
Supportive Care in Cancer (2023) Vol. 31, Iss. 9
Closed Access | Times Cited: 11
Ana Myriam Lavín‐Pérez, Daniel Collado‐Mateo, Shaghayegh Abbasi, et al.
Supportive Care in Cancer (2023) Vol. 31, Iss. 9
Closed Access | Times Cited: 11
hVps37A Status Affects Prognosis and Cetuximab Sensitivity in Ovarian Cancer
Michael Wittinger, Petr Vaňhara, Ahmed El‐Gazzar, et al.
Clinical Cancer Research (2011) Vol. 17, Iss. 24, pp. 7816-7827
Open Access | Times Cited: 43
Michael Wittinger, Petr Vaňhara, Ahmed El‐Gazzar, et al.
Clinical Cancer Research (2011) Vol. 17, Iss. 24, pp. 7816-7827
Open Access | Times Cited: 43
FCGR2A and FCGR3A polymorphisms and clinical outcome in metastatic colorectal cancer patients treated with first-line 5-fluorouracil/folinic acid and oxaliplatin +/- cetuximab
Janne B Kjersem, Eva Skovlund, Tone Ikdahl, et al.
BMC Cancer (2014) Vol. 14, Iss. 1
Open Access | Times Cited: 37
Janne B Kjersem, Eva Skovlund, Tone Ikdahl, et al.
BMC Cancer (2014) Vol. 14, Iss. 1
Open Access | Times Cited: 37
Enhanced NK cell adoptive antitumor effects against breast cancer in vitro via blockade of the transforming growth factor-β signaling pathway
Dongwei Zhang, Yue Zhao, Yujuan Kang, et al.
OncoTargets and Therapy (2015), pp. 1553-1553
Open Access | Times Cited: 34
Dongwei Zhang, Yue Zhao, Yujuan Kang, et al.
OncoTargets and Therapy (2015), pp. 1553-1553
Open Access | Times Cited: 34
